公开(公告)号：CZ20030156A3

公开(公告)日：2003-06-18

申请号：CZ20030156

申请日：2001-07-12

Applicant: SOLVAY PHARM GMBH

Inventor： HEBEBRAND JOHANNES ,  ANTEL JOCHEN ,  PREUSCHOFF ULF ,  DAVID SAMUEL ,  SANN HOLGER ,  WESKE MICHAEL

IPC: G01N33/50 ,  A61K45/00 ,  A61P1/00 ,  A61P3/04 ,  C12Q1/02 ,  C12Q1/527 ,  G01N33/15 ,  A61P3/00

CPC classification number: C12Q1/527

公开(公告)号：NO20030233A

公开(公告)日：2003-03-19

申请号：NO20030233

申请日：2003-01-17

Applicant: SOLVAY PHARM GMBH

Inventor： HEBEBRAND JOHANNES ,  ANTEL JOCHEN ,  PREUSCHOFF ULF ,  DAVID SAMUEL ,  SANN HOLGER ,  WESKE MICHAEL

IPC: G01N33/50 ,  A61K45/00 ,  A61P1/00 ,  A61P3/04 ,  C12Q1/02 ,  C12Q1/527 ,  G01N33/15 ,  C12Q1/34 ,  A61P3/06 ,  G01N33/68

CPC classification number: C12Q1/527

公开(公告)号：AU7753401A

公开(公告)日：2002-02-05

申请号：AU7753401

申请日：2001-07-12

Applicant: SOLVAY PHARM GMBH

Inventor： HEBEBRAND JOHANNES ,  ANTEL JOCHEN ,  PREUSCHOFF ULF ,  DAVID SAMUEL ,  SANN HOLGER ,  WESKE MICHAEL

IPC: G01N33/50 ,  A61K45/00 ,  A61P1/00 ,  A61P3/04 ,  C12Q1/02 ,  C12Q1/527 ,  G01N33/15

Abstract: Compounds for the treatment and/or prevention of obesity are selected on the basis of their capability to inhibit de novo lipogenesis in mammals. An independent claim is also included for the use of compounds which are capable of inhibiting de novo lipogenesis in mammals and which have no anticonvulsant activity for the production of a medicament for the treatment and/or prevention of obesity. - ACTIVITY : Anorectic. - MECHANISM OF ACTION : Lipogenesis inhibitor; Carboanhydrase inhibitor. No biological data given.